Gene Therapy - Correcting Defective Genes
Versatile options to optimize your vector strategy
Development of modern gene therapy approaches necessitates exact gene delivery and gene expression control to be suited for the highly complex in vivo environments.
The SIRION technology platform offers versatile options to identify and optimize the best possible approach for YOUR R&D.
Combined with CRISPR/Cas and other gene editing technologies, even difficult modalities such as gene knockout or repair of defective genes can be accomplished.
- Tissue specific AAV design.
- Lentivirus retargeting to pinpoint cell specific expression.
CONTACT US – Discuss how we can add value to your therapeutic R&D.